Literature DB >> 21775983

Use of inflammatory markers to guide cancer treatment.

S J Clarke1, W Chua, M Moore, S Kao, V Phan, C Tan, K Charles, D C McMillan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21775983     DOI： 10.1038/clpt.2011.122

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  24 in total

Review 1.  Neutrophils in the Tumor Microenvironment.

Authors:  Davalyn R Powell; Anna Huttenlocher
Journal:  Trends Immunol       Date:  2015-12-14       Impact factor: 16.687

2.  Lung cancer resection in octogenarian patients.

Authors:  Lorenzo Spaggiari; Francesco Petrella; Paolo Maione; Cesare Gridelli
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 3.  GUCY2C molecular staging personalizes colorectal cancer patient management.

Authors:  Jian P Gong; Stephanie Schulz; Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2012-06       Impact factor: 2.851

4.  Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer.

Authors:  Yize Mao; Yan Fu; Yunfei Gao; Ankui Yang; Quan Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-23       Impact factor: 2.503

5.  Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.

Authors:  Mao-Song Lin; Jun-Xing Huang; Hong Yu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.

Authors:  Mehmet Kaynar; Mehmet Erol Yıldırım; Hüseyin Badem; Mücahit Caviş; Erdem Tekinarslan; Mustafa Okan Istanbulluoğlu; Ömer Faruk Karataş; Ersin Çimentepe
Journal:  Tumour Biol       Date:  2014-04-03

7.  Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma.

Authors:  A Kinoshita; H Onoda; N Imai; A Iwaku; M Oishi; N Fushiya; K Koike; H Nishino; H Tajiri
Journal:  Br J Cancer       Date:  2012-08-09       Impact factor: 7.640

8.  A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

Authors:  M J Proctor; D C McMillan; D S Morrison; C D Fletcher; P G Horgan; S J Clarke
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640

9.  Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.

Authors:  M Cummings; L Merone; C Keeble; L Burland; M Grzelinski; K Sutton; N Begum; A Thacoor; B Green; J Sarveswaran; R Hutson; N M Orsi
Journal:  Br J Cancer       Date:  2015-06-16       Impact factor: 7.640

10.  A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.

Authors:  Dongsheng Zhou; Yaojun Zhang; Li Xu; Zhongguo Zhou; Junting Huang; Minshan Chen
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.